Research and Markets: A Comprehensive Report on Bioarrays for Life Science Research, Diagnostics and Drug R&D.

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/dee4a3/bioarrays_for_life) has announced the addition of the "Bioarrays for Life Science Research, Diagnostics and Drug R&D" report to their offering.

This research report is about the worldwide bioarray tools, technologies and services market. Bioarrays are also known as DNA microarrays, protein arrays, or biochips. These key mainstream life science research products and services involve technologies that scientists use to detect and analyze genetic and protein material such as DNA, RNA, proteins, antibodies, stem cells, tissues, biomarkers and so on. This study takes into account the impact of key economic factors influencing this industry including the severe global recession of 2008-2009, pharmaceutical industry structural changes, the potential effect of government stimulus programs on life science research, ideas about healthcare reform and more.

This report discusses new bioarray products reaching the market including DNA and RNA products such as high-density arrays, tiling, copy number variation, SNPs, alternate splice variant arrays, ChIP-Chip, CpG island, DNA methylation, microRNA, sequence-capture arrays for targeted resequencing, array-based molecular diagnostics and related areas. The study reviews microfluidic bioarrays such as for POC diagnostics through credit card-sized devices, for liquid chromatography, or for drug discovery optimization. This study also discusses commercial developments in protein bioarrays and SPR biosensors.

The study shows that bioarray product and service vendors are navigating a challenging market. The report discusses the major areas of this dynamic market landscape. This report shows various views of this growing multi-billion dollar market. The report estimates that over its five-year forecast that the bioarray product and services market would reach a high single-digit growth rate (CAGR). The report charts the developments of numerous companies involved in this rapidly changing and evolving industry.

This broad study provides interesting data and includes more than 64 tables and figures. The tables include data about technologies, companies, future product roadmaps, and more. The report presents partnering deals and includes several years of alliance and M&A data. The report reviews twenty-four selected companies, with details including contact information, business and product overviews, alliances and patents or other details. This fully searchable PDF report helps busy readers save time. This report uses hyperlinks to help readers jump to Table of Content items or to text-linked Internet sites.

This must-have report would benefit people with job titles including CEO, VPs, Director of Business Development, Research Directors, Entrepreneurs, Venture Capitalists, Investment Planners, Research Scientists, Consultants or Industry Analysts.

Key Topics Covered:

1. Market Overview
2. Genetic Bioarray Products & Services
3. Protein Bioarrays And Instruments
4. Microfluidic Bioarrays And Instruments
5. Activities Of Selected Bioarray Companies
6. Findings And High Growth Areas
7. Appendix

Companies Mentioned:

* Affymetrix, Inc.

* Agilent Technologies, Inc., BAM

* Applied Microarrays, Inc.

* ArrayIt Corporation

* Biolog, Inc.

* BioMicro Systems, Inc.

* Bio-Rad Laboratories, Inc.

* Caliper Life Sciences, Inc.

* CapitalBio Corporation

* CombiMatrix Corporation

* Eppendorf AG

* Expression Analysis, Inc.

* Fluidigm Corporation

* GenTel BioSciences, Inc.

* GWC Technologies, Inc.

* Illumina, Inc.

* Life Technologies, Inc.

* Ocimum Biosolutions, Inc.

* Oxford Gene Technology Ltd.

* SABiosciences Corporation

* SciGene Corporation

* Sequenom, Inc.

* Sigma-Aldrich Corporation

* Tecan Group AG

For more information visit http://www.researchandmarkets.com/research/dee4a3/bioarrays_for_life